Effect of age and gender on EBV associated-Hodgkin lymphoma among sample of Iraqi patients
Bibliographic Data
| ID | 15796203 |
|---|---|
| Authors | Liqaa Hadi Naser (University of Kufa, corresponding author), Kifah Fadhil Hassoon (0000-0002-9454-7415, University of Kufa) |
| Year | 2022 |
| Pages | 5812-5818 |
| Publication date | 2022-08-15 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | International Journal of Health Sciences (JOURNAL) |
| Journal identifiers | ISSN: 2550-696X • E-ISSN: 2550-6978 |
| Publisher | Universidad Tecnica de Manabi (PUBLISHER • EC) |
| DOI | 10.53730/ijhs.v6ns6.11786 |
| OpenAlex | W4291595236 |
| Language | EN |
| References cited | 3 |
Background: Data on the age-specific prevalence of Epstein–Barr virus (EBV) infection. According to most studies, by the age of 35, more than 90% of adults are EBV antibody positive. Comparison of demographic groups could identify factors associated with its acquisition. Methods: The Present study conducted in AL-Najaf Holy City; it is a cross sectional study. All patients were recruited from Middle Euphrates Cancer Research Unit Laboratory, from pre-existing samples. Tissues collected from the previously mentioned laboratory were fixed in 10% formalin and placed in a cassette before being embedded in paraffine. The tissues were examined and diagnosed as with Hodgkin disease. forty samples were subjected in the present study. All study group was diagnosed formerly as paraffin imbedding blocks. Histopathological examination using hematoxylin and eosine stain (H&E) then examining under light microscope to check for twenty block samples of tissues with lymphoma. Results: From a total of 40 FFPET blocks were tested. The mean age was 34.92 years. The age group prevalence was as follows: ≤10 years, 2.5%; 10–20 years, 25%; 21–30 years, 22.5%; 31–40 years, 10%; and 41–50 years, 20%; ≥ 50, 20
Age groups · Lymphoma · Pathology · Stain · Staining · Demography · Lymphoma Diagnosis and Treatment · Medicine · Parvovirus B19 Infection Studies · Viral-associated cancers and disorders · Internal Medicine
| Highly cited | No |
|---|